HOME >> BIOLOGY >> NEWS
Women who drink moderately do not face a longer wait to become pregnant

Women who regularly drink a moderate amount of alcohol while trying to conceive do not have to wait longer than teetotallers to become pregnant, according to new research published today (Thursday 29 November) in Europes leading reproductive medicine journal, Human Reproduction*.

In fact, the study shows that women who do not drink at all can actually take longer to become pregnant than those women who consume an average of between a half and 14 alcoholic drinks a week.

The study of nearly 40,000 women in Denmark is large enough to offer reassuring evidence which contradicts the findings of previous, smaller studies suggesting that even low levels of alcohol intake are associated with longer waiting times to pregnancy. In women who had never given birth before, neither moderate nor high alcohol intake was related to a longer waiting time to pregnancy.

However Mette Juhl, the Danish researcher who headed the study, sounded a cautionary note: Our research does not mean that consuming alcohol is better for fertility than not drinking alcohol at all. It is known from other studies that non-drinkers differ from moderate drinkers in many other aspects; for instance they may have a weaker constitution or other health problems which can influence fertility, directly or indirectly, she said.

Ms Juhl and her colleagues, from centres in Copenhagen and Aarhus, did find that women who had given birth before and who consumed more than the Danish recommended maximum weekly intake of 14 alcoholic drinks did have to wait longer to get pregnant. However, the evidence from the study was not strong for this as there were few women in this group. Older women and women who smoked or who were over-weight also had to wait longer to become pregnant. Non-drinking, over-weight women had to wait the longest of all. These findings support the evidence of previous studies.

The study was carried out within the Danish National Birth Cohort, a nationwide stud
'"/>

Contact: Emma Mason
wordmason@aol.com
44-1376-563-090
European Society for Human Reproduction and Embryology
28-Nov-2001


Page: 1 2 3

Related biology news :

1. Women who have donated eggs sought for national study
2. Donaghue Womens Health Investigator Program awards grants to three at Yale
3. Top Houston Women in Technology honoree at UH
4. Marie Curie Nobel Centennial Celebration of Women in Science
5. Victoria Hale of Institute for OneWorld Health Named Fellow by International Womens Forum
6. Women who drink may be at greater risk of cardiovascular complications than men
7. Jefferson and Brigham and Womens researchers find blue light important for setting biological clock
8. Women are more likely to suffer recurrent miscarriages if their first child is a boy
9. Womens health issues, child and adolescent disorders featured at APAs annual meeting
10. Women who marry alcoholics
11. Pregnancy hormone induces healthy blood vessels, Magee-Womens Research Institute scientists report

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Women who drink moderately not face longer wait become pregnant

(Date:8/25/2015)... LAKE CITY and BELLEVUE, Wash. ... global leader in advanced robotic systems, announced today it ... robotic unmanned ground vehicle (UGV), at the National Tactical ... City.  The Guardian S is the ... the culmination of years of research and in-field trials ...
(Date:8/20/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market and creator of the ... Card Alliance and the EMV Migration Forum.  ... Card Alliance Latin America (SCALA) Chapter provides NXT-ID, Inc. ... leaders promoting adoption of smart card technology. ...
(Date:8/12/2015)... , Aug. 12, 2015   MedNet Solutions ... the entire spectrum of clinical research, is proud to ... the company,s comprehensive SaaS-based eClinical technology platform, has led ... the first two quarters of 2015.   Q2 2015 ... largest quarters measured by contract value sold in the ...
Breaking Biology News(10 mins):Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 2NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 4MedNet Solutions Experiences Explosive Corporate Growth 2
(Date:9/2/2015)... , Sep. 02, 2015 ... announced the addition of Jain PharmaBiotech,s new report ... to their offering. This report follows ... characteristic that can be objectively measured and evaluated ... processes as well as pharmacological responses to a ...
(Date:9/2/2015)... , Sept. 2, 2015  Neurotech Pharmaceuticals, Inc., ... in the multicenter Phase 2 clinical trial of ... treatment of recurrent subfoveal choroidal neovascularization secondary to ... a unique vascular endothelial growth factor (VEGF) receptor ... "This landmark proof-of-concept study will evaluate ...
(Date:9/2/2015)... , September 2, 2015 BiondVax ... of the National Institute of Allergy and Infectious Diseases (NIAID), ... the Department of Health and Human Services (HHS), to launch ... the United States in the 2015-16 timeframe. ... vaccine candidate, Multimeric-001 (M-001), as a primer vaccine, which would ...
(Date:9/2/2015)... ... September 02, 2015 , ... The ... creating professional commercial video content, to analysis of athletic performance. Producing high-resolution ... go by too quickly to process with the naked eye. , Slow ...
Breaking Biology Technology:Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 3
Cached News: